Similar articles

• Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis.

  Heymann MA, Rudolph AM, Silverman NH. Heymann MA, et al. N Engl J Med. 1976 Sep 2;295(10):530-3. doi: 10.1056/NEJM197609022951004. N Engl J Med. 1976. PMID: 950959
• [Therapeutic problems with indomethacin in preterm infants with persistent ductus arteriosus].

  Seyberth HW, Müller H, Wille L, Plückthun H, Ulmer HE, Wolf D. Seyberth HW, et al. Monatsschr Kinderheilkd. 1983 Feb;131(2):71-6. Monatsschr Kinderheilkd. 1983. PMID: 6843560 German.
• Indomethacin for closure of patent ductus arteriosus in preterm neonates.

  Nair PA, Karan S. Nair PA, et al. Indian J Pediatr. 1986 Jul-Aug;53(4):499-503. Indian J Pediatr. 1986. PMID: 3804391 No abstract available.
• [Drug therapy of patent ductus arteriosus in premature and newborn infants].

  Bartel J. Bartel J. Kinderarztl Prax. 1978 Dec;46(12):644-8. Kinderarztl Prax. 1978. PMID: 366238 Review. German. No abstract available.
• Patent ductus arteriosus. Clinical relevance of prostaglandins and prostaglandin inhibitors in PDA pathophysiology and treatment.

  Hammerman C. Hammerman C. Clin Perinatol. 1995 Jun;22(2):457-79. Clin Perinatol. 1995. PMID: 7671547 Review.